Propel Forward – Gaurav Mehta

In this conversation, Naji Gehchan sat with Gaurav Mehta CEO at Alveolus Bio, and discussed several deep topics from leadership to happiness and being content, and also the current biotech world and its challenges. Gaurav emphasized that leadership involves self-awareness and humility, aiming for productive outcomes that benefit investors, teams, products, and patients. He linked innovation to combining ideas with execution, highlighting the importance of bringing one's best self forward to inspire teams and sell ideas passionately. Regarding entrepreneurship, Gaurav stressed shedding self-limiting storylines, allowing inner genius to flourish, and being open to pivoting when necessary. The conversation also touched on vulnerability, humility, and genuine connections as essential for spreading love within organizations. Gaurav encouraged us all as healthcare leaders to set ambitious goals to tackle significant healthcare challenges effectively.

"Get rid of the storylines you have in your head"

MEET OUR GUEST Gaurav Mehta, CEO at Alveolus Bio.

Gaurav Mehta is the Chief Executive Officer at Alveolus Bio, a biotech Harnessing the power of the microbiome for the prevention and treatment of lung disease. Gaurav has raised multi-million dollars in the form of dilutive and non-dilutive money. He also has progressed long term global strategic partnership deals that authenticate his team, their capabilities, and science with the intent of obtaining investments for his company. He has also created a revenue-generating-business to create value, sustain the company in market volatility and mitigate dilution. While in this capacity, he also advises multiple life science businesses.

Gaurav has co-founded multiple companies. His 20 years of building and scaling depth include having led global operations, business transformations, top and bottom-line improvements, M&A execution, and a turn-around.

This experience has been across large to small firms around the globe in BioTech, MedTech, digital health, and tech.